NATURAL SEROCONVERSION FROM HEPATITIS-BE ANTIGEN TO ANTIBODY AMONG HEPATITIS-B VIRUS CARRIERS IN OKINAWA-ISLANDS

被引:21
作者
SAKUGAWA, H [1 ]
OHWAN, T [1 ]
YAMASHIRO, A [1 ]
OYAKAWA, T [1 ]
KADENA, K [1 ]
KINJO, F [1 ]
SAITO, A [1 ]
机构
[1] UNIV RYUKYUS,SCH MED,FAC MED,DEPT INTERNAL MED 1,NAHA,OKINAWA 903,JAPAN
关键词
HEPATOCELLULAR CARCINOMA; HBV; ANTI-HBE;
D O I
10.1002/jmv.1890340210
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the Okinawa Islands, the great majority of hepatitis B surface antigen (HBsAg) carriers have already acquired antibody to hepatitis Be antigen (anti-HBe) by the age of 30 years (preliminary cross-sectional data). To elucidate natural seroconversion from hepatitis Be antigen (HBeAg) to anti-HBe among HBsAg carriers found in the islands of Okinawa Prefecture, 34 HBeAg-positive HBsAg carriers were followed for 1-6 years with serial measurements of aminotransferase levels, HBeAg, and anti-HBe. The 34 subjects included 24 patients with chronic hepatitis (group 1) and ten asymptomatic HBsAg carriers (group 2). During the follow-up period, HBeAg disappeared from 14 subjects in group 1 with the cumulative clearance rate of HBeAg of 56.3% within the first 2 years and with 10 of the 14 subsequently developing anti-HBe. Moreover, the aminotransferases in 12 of the 14 spontaneously seroconverted fell into the normal range. The annual clearance rates of HBeAg among group 1 and group 2 were 25.6% and 9.3%, respectively. The tendency for early disappearance of HBeAg during a carrier's life time or in the course of chronic hepatitis may lead to the low death rate from hepatocellular carcinoma (HCC) particularly HCC associated with hepatitis B virus infection in this area.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 29 条
[1]   THE EXPRESSION PATTERN OF HEPATITIS-B E-ANTIGEN AND ANTIBODY IN DIFFERENT ETHNIC AND CLINICAL GROUPS OF HEPATITIS-B SURFACE-ANTIGEN CARRIERS [J].
ALDERSHVILE, J ;
SKINHOJ, P ;
FROSNER, GG ;
BLACK, F ;
DEINHARDT, F ;
HARDT, F ;
NIELSEN, JO .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (01) :18-22
[2]  
BEASLEY RP, 1981, LANCET, V2, P1129
[3]   WHICH PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION WILL RESPOND TO ALPHA-INTERFERON THERAPY - A STATISTICAL-ANALYSIS OF PREDICTIVE FACTORS [J].
BROOK, MG ;
KARAYIANNIS, P ;
THOMAS, HC .
HEPATOLOGY, 1989, 10 (05) :761-763
[4]   NATURAL-HISTORY OF CHRONIC HEPATITIS-B VIRUS-INFECTION IN TAIWAN - STUDIES OF HEPATITIS-B VIRUS-DNA IN SERUM [J].
CHU, CM ;
KARAYIANNIS, P ;
FOWLER, MJF ;
MONJARDINO, J ;
LIAW, YF ;
THOMAS, HC .
HEPATOLOGY, 1985, 5 (03) :431-434
[5]  
DOW BC, 1980, J CLIN PATHOL, V33, P1160
[6]   CLINICAL, VIROLOGICAL AND HISTOLOGIC OUTCOME FOLLOWING SEROCONVERSION FROM HEBEAG TO ANTI-HBE IN CHRONIC HEPATITIS TYPE-B [J].
FATTOVICH, G ;
RUGGE, M ;
BROLLO, L ;
PONTISSO, P ;
NOVENTA, F ;
GUIDO, M ;
ALBERTI, A ;
REALDI, G .
HEPATOLOGY, 1986, 6 (02) :167-172
[7]   CHRONIC TYPE-B HEPATITIS AND THE HEALTHY HBSAG CARRIER STATE [J].
HOOFNAGLE, JH ;
SHAFRITZ, DA ;
POPPER, H .
HEPATOLOGY, 1987, 7 (04) :758-763
[8]   SEROCONVERSION FROM HEPATITIS-B-E ANTIGEN TO ANTIBODY IN CHRONIC TYPE-B HEPATITIS [J].
HOOFNAGLE, JH ;
DUSHEIKO, GM ;
SEEFF, LB ;
JONES, EA ;
WAGGONER, JG ;
BALES, ZB .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (06) :744-748
[9]   AGE-SPECIFIC PREVALENCE OF HEPATITIS-BE ANTIGEN (HBEAG) AND ANTIBODY TO HBEAG (ANTI-HBE) AMONG ASYMPTOMATIC HEPATITIS-B SURFACE-ANTIGEN (HBSAG) CARRIERS IN OKINAWA AND KYUSHU, JAPAN [J].
KASHIWAGI, S ;
HAYASHI, J ;
NOMURA, H ;
KAJIYAMA, W ;
IKEMATSU, H ;
SHINGU, T ;
HAYASHIDA, K ;
KAJI, M .
MICROBIOLOGY AND IMMUNOLOGY, 1986, 30 (07) :675-682
[10]   TRANSMISSION OF HEPATITIS-B VIRUS AMONG SIBLINGS [J].
KASHIWAGI, S ;
HAYASHI, J ;
IKEMATSU, H ;
NOMURA, H ;
KAJIYAMA, W ;
SHINGU, T ;
HAYASHIDA, K ;
KAJI, M .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 120 (04) :617-625